Related Experiment Video
Updated: Mar 16, 2026

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.9K
Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration
Erin Greenwood1, Sabrina Maisel2,3, David Ebertz1
1Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona.
Oncotarget
|August 20, 2016
Summary
Loss of Llgl1 promotes pre-neoplastic changes by causing Epidermal Growth Factor Receptor (EGFR) mislocalization. This enhances cell migration and survival, driving fundamental shifts in cellular phenotype and promoting tumor-like characteristics.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Biology
Background:
- Loss of Llgl1 (Lethal giant larvae homolog 1) is associated with mesenchymal phenotypes and polarity loss.
- Llgl1 regulates cell identity markers and key signaling pathways.
Purpose of the Study:
- To investigate the fundamental cellular and molecular changes induced by Llgl1 loss.
- To determine the role of Epidermal Growth Factor Receptor (EGFR) in Llgl1-deficient phenotypes.
Main Methods:
- Analysis of cell identity markers (CD44, CD49f, CD24).
- Assessment of TAZ and Slug nuclear translocation.
- Mammosphere formation assays and soft-agar growth.
- Orthotopic transplantation in NOD-SCID mice.
- Lineage tracing and wound healing experiments.
- Investigation of EGFR mislocalization and mutation effects.
Main Results:
- Llgl1 loss induces a fundamental shift in cellular phenotype, promoting mesenchymal characteristics.
- Cells lacking Llgl1 form mammospheres dependent on EGFR for survival and transplantability.
- Enhanced EGF-dependent migration and prolonged survival in orthotopic transplants observed.
- Llgl1 loss drives EGFR mislocalization, which, along with a specific mutation (P667A), activates AKT and TAZ nuclear translocation.
Conclusions:
- Loss of Llgl1 promotes pre-neoplastic changes through EGFR mislocalization.
- EGFR mislocalization is a key driver of enhanced migration, survival, and altered cell signaling.
- These findings highlight a novel mechanism linking Llgl1 function to EGFR regulation in cancer progression.
Related Concept Videos
Mitogens and the Cell Cycle
8.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K

